Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEXUS: Sorafenib plus Gemcitabine/Cisplatin in Advanced Non-Squamous NSCLC
NCT00449033Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of sorafenib in non-small cell lung cancer (NSCLC), sponsored by Bayer. Started Feb 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00449033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449033.